Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 6
1987 4
1988 5
1989 8
1990 3
1991 5
1992 7
1993 9
1994 5
1995 3
1996 5
1997 5
1998 2
1999 3
2000 1
2001 1
2003 1
2005 2
2006 4
2007 2
2008 1
2009 8
2010 2
2011 5
2012 7
2013 9
2014 8
2015 6
2016 3
2017 2
2018 4
2019 6
2020 7
2021 7
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: luquin mr. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.
Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR. Espinoza-Vinces C, et al. Among authors: luquin mr. Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 37840836 Free PMC article. Review.
[Presentation].
García-Ruiz PJ, Luquin MR, Martínez-Castrillo JC. García-Ruiz PJ, et al. Among authors: luquin mr. Rev Neurol. 2012;55 Suppl 1:S1. Rev Neurol. 2012. PMID: 23169226 Spanish. No abstract available.
Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models.
Vinueza-Gavilanes R, Bravo-González JJ, Basurco L, Boncristiani C, Fernández-Irigoyen J, Santamaría E, Marcilla I, Pérez-Mediavilla A, Luquin MR, Vales A, González-Aseguinolaza G, Aymerich MS, Aragón T, Arrasate M. Vinueza-Gavilanes R, et al. Among authors: luquin mr. Neurobiol Dis. 2023 Jul;183:106166. doi: 10.1016/j.nbd.2023.106166. Epub 2023 May 26. Neurobiol Dis. 2023. PMID: 37245833 Free article.
[Neuropsychological profile of frontotemporal lobar degeneration].
Carmona-Abellán MM, Luquin MR, Lamet I, Pujol Giménez N, Esteve-Belloch P, Rivero M. Carmona-Abellán MM, et al. Among authors: luquin mr. An Sist Sanit Navar. 2015 Jan-Apr;38(1):79-92. doi: 10.23938/ASSN.0056. An Sist Sanit Navar. 2015. PMID: 25963461 Free article. Review. Spanish.
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, Íñiguez-Alvarado MC, García Díaz I, Jesús S, Buongiorno MT, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Ruiz Martínez J, Valero C, Kurtis M, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Calopa M, Carrillo F, Escamilla Sevilla F, Freire-Alvarez E, Gómez Esteban JC, García Ramos R, Luquín MRI, Martínez-Torres I, Sesar Ignacio Á, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: luquin mri. J Parkinsons Dis. 2023;13(3):379-402. doi: 10.3233/JPD-225073. J Parkinsons Dis. 2023. PMID: 36911948 Free PMC article.
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R. Kulisevsky J, et al. Among authors: luquin mr. Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Neurologia. 2013. PMID: 23880230 Free article. Review. English, Spanish.
Structural and functional neuroimaging in human prion diseases.
Ortega-Cubero S, Luquín MR, Domínguez I, Arbizu J, Pagola I, Carmona-Abellán MM, Riverol M. Ortega-Cubero S, et al. Among authors: luquin mr. Neurologia. 2013 Jun;28(5):299-308. doi: 10.1016/j.nrl.2011.03.012. Epub 2011 May 31. Neurologia. 2013. PMID: 21621879 Free article. Review. English, Spanish.
Hydrogels for brain repair: application to Parkinson's disease.
Del Campo-Montoya R, Luquin MR, Puerta E, Garbayo E, Blanco-Prieto MJ. Del Campo-Montoya R, et al. Among authors: luquin mr. Expert Opin Drug Deliv. 2022 Nov;19(11):1521-1537. doi: 10.1080/17425247.2022.2136161. Epub 2022 Nov 1. Expert Opin Drug Deliv. 2022. PMID: 36240170
158 results